Trial Profile
Propensity score matched study of collagenase clostridium histolyticum versus limited fasciectomy, in patients with dupuytren's contracture
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Sep 2015
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Therapeutic Use
- 23 Sep 2015 New trial record
- 01 Jul 2015 Results published in the Plastic and Reconstructive Surgery.